Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Action inhibitors |
Mechanism CEACAM6 inhibitors(Carcinoembryonic antigen related cell adhesion molecule 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bile Duct Neoplasms | Preclinical | Taiwan Province | 27 Apr 2025 | |
Colorectal Cancer | Preclinical | Taiwan Province | 27 Apr 2025 | |
Lung Cancer | Preclinical | Taiwan Province | 27 Apr 2025 | |
Pancreatic Cancer | Preclinical | Taiwan Province | 27 Apr 2025 |